Management of Abdominal Aortic Aneurysm
For AAA management, use ultrasound for surveillance with intervals based on size: every 3 years for 3.0-3.9 cm, annually for 4.0-4.9 cm in men (4.0-4.4 cm in women), and every 6 months for ≥5.0 cm in men (≥4.5 cm in women); repair when diameter reaches ≥5.5 cm in men or ≥5.0 cm in women. 1, 2
Initial Evaluation and Imaging
Ultrasound is the primary imaging modality for AAA diagnosis and surveillance due to cost-effectiveness and lack of radiation exposure 1, 2, 3. When ultrasound provides inadequate visualization, use CT angiography for precise measurement 1, 2. MRI is a reasonable alternative when CT is contraindicated or to reduce cumulative radiation exposure 1.
For preoperative planning once repair criteria are met, CT angiography is mandatory to assess anatomy and plan the surgical approach 1.
Surveillance Intervals by Size
The 2024 ESC guidelines 2 and 2022 ACC/AHA guidelines 1 provide concordant surveillance recommendations:
Small AAAs (3.0-3.9 cm)
Medium AAAs
- Men 4.0-4.9 cm: Annual ultrasound 1, 2
- Women 4.0-4.4 cm: Annual ultrasound 1, 2
- Consider shorter intervals (every 6 months) in smokers or diabetics due to accelerated growth 1
Large AAAs Approaching Repair Threshold
- Men ≥5.0 cm: Every 6 months 1, 2
- Women ≥4.5 cm: Every 6 months 1, 2
- More frequent monitoring is critical as rupture risk increases exponentially with each 0.5 cm increase (hazard ratio 1.91) 4
Critical caveat: If rapid growth occurs (≥10 mm/year or ≥5 mm per 6 months), consider earlier repair regardless of absolute diameter 2.
Medical Management
All AAA patients require aggressive cardiovascular risk reduction to decrease mortality from concurrent cardiovascular disease 2:
- Smoking cessation is mandatory - smoking accelerates AAA growth 1, 3
- Blood pressure control - particularly with ACE inhibitors based on observational data suggesting reduced rupture risk 5
- Statin therapy - for cardiovascular risk reduction, though no proven effect on AAA growth 5
- Avoid fluoroquinolones unless absolutely necessary with no alternatives, as they may increase rupture risk 2
Important limitation: Despite 13 randomized trials testing various medications (antibiotics, antihypertensives, antiplatelet agents, fenofibrate), no drug therapy has convincingly slowed AAA growth 5. Metformin shows promise in observational studies and is under investigation 5.
Regarding antiplatelet therapy: Evidence is conflicting. Low-dose aspirin does not increase rupture risk but may worsen outcomes if rupture occurs 2. Use aspirin only if concomitant coronary artery disease is present 2.
Criteria for Surgical Repair
Repair is indicated when:
- Men: AAA diameter ≥5.5 cm 1, 2, 3
- Women: AAA diameter ≥5.0 cm 1, 2, 3
- Any symptomatic AAA (abdominal/back pain suggesting expansion or impending rupture)
- Rapid growth (≥10 mm/year or ≥5 mm per 6 months) 2
Women have lower diameter thresholds because they experience four-fold higher rupture risk at equivalent diameters compared to men 2.
Surgical Options
Both open surgical repair and endovascular aneurysm repair (EVAR) are acceptable approaches. The choice depends on:
- Patient anatomy and suitability for endovascular approach
- Surgical risk assessment
- Patient preference after shared decision-making
- Local expertise
For ruptured AAA: This is a surgical emergency requiring immediate intervention with mortality rates exceeding 50% without repair 3.
Key Pitfalls to Avoid
- Don't use inconsistent imaging modalities - stick with the same technique (preferably ultrasound) for serial measurements to ensure accuracy
- Don't measure diameter incorrectly - use 3D imaging with centerline positioning when available for most accurate maximum diameter 6
- Don't forget sex-specific thresholds - women require repair at smaller diameters (5.0 cm vs 5.5 cm)
- Don't delay imaging in rapid growers - accelerated expansion warrants consideration for repair before reaching absolute size thresholds
- Don't neglect cardiovascular risk management - most AAA patients die from cardiac events, not rupture 2